Tethys Bioscience, Inc. – Trademark Portfolio

Entity Type: 03

Tethys Bioscience, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. The owner is based in Emeryville, CA.

5858 Horton Street, Suite 280

Emeryville, CA 94608

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tethys Bioscience, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (6 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Tethys Bioscience, Inc. have?

Tethys Bioscience, Inc. has 11 U.S. trademarks filed with the USPTO.

What trademark classes does Tethys Bioscience, Inc. file in?

Tethys Bioscience, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What is Tethys Bioscience, Inc.'s trademark registration success rate?

Tethys Bioscience, Inc. has a 0% trademark registration rate, with 0 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.